This guidance is intended to assist manufacturers, sponsors, and applicants developing dried plasma products intended for transfusion in order to facilitate the availability of safe and effective dried plasma1 products in the United States (U.S.).
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2sIjrp4
No comments:
Post a Comment